Skip to main content
Welcome to "The Poster!" To become a subscriber and start getting updates on new content, subscribe now!

In the News

People | Meet the Contributing Writers

As we begin the 2022 fiscal year and prepare to enter calendar year 2022, we on the editorial team want to take a moment to introduce ourselves to you. First up are our contributing writers, staff in program areas around our institutions who pitch ideas and cover topics related to those groups. Read on to meet them.

Science & Technology | Though Rare, HIV Leads to Blood Cancers

HIV plays a direct role in causing blood cell cancers in rare instances, says a new study of HIV and tumor DNA. Scientists have long known that HIV contributes to several cancers by weakening the immune system’s ability to fend off cancer-causing infections. However, this latest study, published in Science Advances this week, is the first to demonstrate HIV as a cause.

Health & Safety | It’s Time for a Flu Shot! Here’s What You Need to Know.

With all the talk around COVID-19 vaccines and boosters, it's easy to forget there's another infectious respiratory disease already looming: influenza. Flu season is going to look a little different this year, according to Sarah Hooper, nurse practitioner (CRNP), RN, manager of the Frederick National Laboratory Occupational Health Services.

Science & Technology | Manufacturing and Quality Assurance Expertise by Frederick National Laboratory Supports NCI’s Pioneering Cancer Immunotherapy Program

A grim statistic is driving Steven Rosenberg’s mission to find new cancer treatments—and his partnership with Frederick National Laboratory to do so. “Every year in the United States, about 600,000 people die of cancer, 90% of whom die of the solid epithelial cancers,” said Rosenberg, the M.D., Ph.D., chief of the National Cancer Institute’s Surgery Branch, head of the Tumor Immunology Section at NCI’s Center for Cancer Research.

Community | Microscopists Crowdsource Project to Teach AI

NCI at Frederick’s latest class of student interns continues to telework under pandemic protocols. While that means not working in laboratories or offices as they would in a normal year, it doesn’t mean a lack of opportunities to make a difference in science. In fact, according to Kedar Narayan, Ph.D., volume electron microscopy group leader at the Center for Molecular Microscopy, one opportunity is quite unique.